Journal
British journal of clinical pharmacology
Publication Date
10-1-2020
Volume
86
Issue
10
First Page
2063
Last Page
2069
Document Type
Open Access Publication
DOI
10.1111/bcp.14301
Rights and Permissions
Körber, I, Klein, OD, Morhart, P, et al. Safety and immunogenicity of Fc-EDA, a recombinant ectodysplasin A1 replacement protein, in human subjects. Br J Clin Pharmacol. 2020; 86: 2063– 2069. https://doi.org/10.1111/bcp.14301 © 2020 The Authors. British Journal of Clinical Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Recommended Citation
Körber, Iris; Klein, Ophir D; Morhart, Patrick; Faschingbauer, Florian; Grange, Dorothy K; Clarke, Angus; Bodemer, Christine; Maitz, Silvia; Huttner, Kenneth; Kirby, Neil; Durand, Caroline; and Schneider, Holm, "Safety and immunogenicity of Fc-EDA, a recombinant ectodysplasin A1 replacement protein, in human subjects." British journal of clinical pharmacology. 86, 10. 2063 - 2069. (2020).
https://digitalcommons.wustl.edu/oa_4/1442
Department
ICTS (Institute of Clinical and Translational Sciences)
